If you have been diagnosed with non-melanoma skin cancer, learn more about a gentler way to treat skin cancer.

Data Security Incident [Click Here].

Find a Practice
Search
Screenshot
Access Journal

Consensus Recommendations

A panel of expert dermatologists reviewed published studies on IGSRT for the treatment of NMSC and created consensus recommendations on its use. They concluded that IGSRT is a safe and effective treatment for NMSC that often results in highly favorable cosmetic outcomes. It can be considered a first-line treatment option for appropriately selected cases of NMSC.

  • SRT is a well-established modality for the treatment of NMSC, dependent on individual patient characteristics.
  • ISGSRT adds US visualization that can help evaluate the depth and breadth of the tumor.
  • IGSRT is a safe and effective treatment option for NMSC.
  • Dermatologists are the most appropriate clinician to direct and administer SRT including IGSRT.
  • SRT including IGSRT can be considered a first line treatment for NMSC for appropriately selected patients.
  • SRT including IGSRT may be the optimal treatment for certain patients dependent on individual patient factors, such as age, comorbidity, patient preferences, tumor location, and tumor histology, and other factors.
  • Patients with NMSC need to be offered all appropriate treatment options and should be a part of the decision-making process.